Jennifer is a PhD candidate Memorial University of Newfoundland’s School of Pharmacy, under the supervision of Drs. John-Michael Gamble and Carlo Marra. She has spent 12 years as a practicing pharmacist, and has prior graduate school training in Health Technology Assessment and Business Administration. She is interested in examining how patient’s preferences towards their medications can be incorporated into decision frameworks.
Her PhD thesis is titled “Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors”. This project will use a Conjoint Based Choice survey design to elicit patient preferences for various attributes of medications used to treat type 2 diabetes, including benefits and potential risks. By pairing preference weights with event probabilities in a benefit-risk analysis, Jennifer will look identify drug therapies that are most likely to derive superior benefit for patients. Since it has been demonstrated that if patients are more satisfied with their medication therapy, they are more likely to be compliant and therefore likely derive the most benefit.
Jennifer’s initial target audience will be guideline developers and policy makers, however, in the long term Jennifer’s hopes to be able to make it easier to incorporate individual patient preferences into decisions right at the clinic level.